Ping Chu Selected Research

Ping Chu Research Topics

Disease

6	Neoplasms (Cancer) 01/2022 - 09/2009
6	Tuberculosis (Tuberculoses) 01/2018 - 01/2013
3	Tularemia 01/2017 - 04/2010
3	Infections 01/2017 - 12/2012
2	Neuroblastoma 07/2019 - 01/2018
2	Carcinogenesis 06/2019 - 05/2018
2	Ovarian Neoplasms (Ovarian Cancer) 05/2018 - 11/2010
2	Poliomyelitis (Polio) 10/2013 - 06/2012
2	Syphilis 01/2013 - 12/2012
1	Polyps 08/2022
1	Endometrial Neoplasms (Endometrial Cancer) 01/2022
1	Pneumonia (Pneumonitis) 01/2021
1	Meningitis 01/2021
1	Deafness (Deaf Mutism) 02/2019
1	Inflammation (Inflammations) 01/2019
1	Neoplasm Metastasis (Metastasis) 05/2018
1	Papillary Thyroid Cancer 01/2018
1	Placenta Previa 01/2018
1	Shock 07/2017
1	Fetal Growth Retardation (Intrauterine Growth Retardation) 07/2017
1	Cognitive Dysfunction 07/2017
1	Rhabdomyosarcoma 01/2017
1	Dyspnea (Shortness of Breath) 11/2016
1	Squamous Cell Carcinoma of Head and Neck 04/2016
1	Extrapulmonary Tuberculosis 04/2014
1	HIV Infections (HIV Infection) 01/2013
1	Acquired Immunodeficiency Syndrome (AIDS) 01/2013
1	Melanoma (Melanoma, Malignant) 09/2011
1	Ovarian Epithelial Carcinoma 11/2010

Drug/Important Bio-Agent (IBA)

5	MicroRNAs (MicroRNA)IBA 01/2022 - 09/2011
5	VaccinesIBA 01/2017 - 04/2010
4	Proteins (Proteins, Gene)FDA Link 02/2019 - 01/2014
3	Biomarkers (Surrogate Marker)IBA 08/2022 - 01/2018
2	Long Noncoding RNAIBA 01/2022 - 07/2019
2	Messenger RNA (mRNA)IBA 01/2022 - 01/2018
2	Interleukin-6 (Interleukin 6)IBA 01/2019 - 03/2015
2	Rifampin (Rifampicin)FDA LinkGeneric 01/2018 - 01/2017
2	Interleukin-10 (Interleukin 10)IBA 03/2015 - 04/2014
2	CytokinesIBA 04/2014 - 01/2014
1	Competitive Endogenous RNAIBA 01/2022
1	human MIRN424 micrornaIBA 01/2022
1	human MIRN211 microRNAIBA 01/2022
1	human MIRN143 microRNAIBA 01/2022
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2021
1	Phosphatidylinositols (Phosphatidylinositol)IBA 01/2020
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 05/2018
1	Smad Proteins (Mothers Against Decapentaplegic Homolog)IBA 05/2018
1	TensinsIBA 05/2018
1	NestinIBA 01/2018
1	Indicators and Reagents (Reagents)IBA 01/2018
1	hydroxide ionIBA 07/2017
1	Vitamin D FDA LinkGeneric 07/2017
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 07/2017
1	Insulin-Like PeptidesIBA 01/2017
1	Interleukin-8 (Interleukin 8)IBA 03/2015
1	LigandsIBA 03/2015
1	LipopeptidesIBA 03/2015
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 03/2015
1	Toll-Like Receptor 1IBA 03/2015
1	CXC ChemokinesIBA 03/2015
1	Attenuated VaccinesIBA 10/2014
1	Interleukin-4 (Interleukin 4)IBA 04/2014
1	Heroin (Diamorphine)IBA 01/2013
1	Pharmaceutical PreparationsIBA 01/2013
1	Synthetic DrugsIBA 01/2013
1	Methadone (Dolophine)FDA LinkGeneric 12/2012
1	2-methylcyclopentadienyl manganese tricarbonyl (MMT)IBA 12/2012
1	Neutralizing AntibodiesIBA 06/2012
1	Glycogen Synthase (Synthase I)IBA 09/2011
1	Gemcitabine FDA Link 11/2010
1	Doxorubicin (Adriamycin)FDA LinkGeneric 11/2010
1	Ifosfamide FDA LinkGeneric 11/2010
1	Mitoxantrone (Novantrone)FDA LinkGeneric 11/2010
1	PlatinumIBA 11/2010
1	Epirubicin (Ellence)FDA LinkGeneric 11/2010
1	AnthracyclinesIBA 11/2010
1	IntegrinsIBA 09/2009

Therapy/Procedure

2	Drug Therapy (Chemotherapy) 01/2018 - 11/2010
1	Resuscitation 11/2016
1	Treatment Delay 01/2013
1	Combination Drug Therapy (Combination Chemotherapy) 11/2010
1	Therapeutics 09/2009